Silver nanoparticles coated with a uniform, thin shell of titanium dioxide are synthesized via a remarkably simple one-pot route, where the reduction of Ag+ to Ag0 and the controlled polymerization of TiO2 on the surface of silver crystallites take place simultaneously. The prepared dispersions of coated nanoparticles display a surface plasmon band, which is significantly red-shifted with respect to that of bare Ag. High-quality ultrathin films of the core−shell clusters are prepared via layer-by-layer assembly. The nanoparticles are arranged in closely packed layers interlaced with polyelectrolyte producing a stratified core−shell hybrid material with unique structure and catalytic and electron-transport properties.
The International Symposium on Phytochemicals in Medicine and Food (ISPMF2015), organized by the Phytochemical Society of Europe (PSE) and the Phytochemical Society of Asia (PSA), was held June 26-29, 2015, in Shanghai of China. This was the first time that a PSE meeting has been held in Asia and a PSE-PSA joint symposium provided an opportunity for communication between scientists from Europe and Asia and other continents. ISPMF2015 has been jointly sponsored by Fujian Agriculture and Forestry University, Guizhou Medical University, Shanghai Normal University, Yancheng Institute of Technology, Beijing Normal University, and Fudan University. More than 270 scientists from 48 countries attended this meeting and presented their research and opinions on phytochemistry, phytomedicine and phytoneering. The international organizing committee and scientific advisory board of ISPMF 2015 comprised of outstanding scientists from around the globe. Dr. Jianbo Xiao was the chairman of the International Organizing Committee of ISPMF2015 and moderated the open address on June 26. The organizing committee of ISPMF2015 assembled an exciting and diverse program, featuring 16 sessions including 12 plenary lectures, 20 invited talks, 55 short oral presentations, and more than 130 posters, which were dedicated to creating a podium for exchanging the latest research results in the phytochemicals for food and human health.
Fish tests must be developed for both regulatory and conservation reasons, as such testing forms an indispensable component of integrated toxicity testing strategy for the marine environment. To standardise a fish embryo test, the acute toxicity of metals and polycyclic aromatic hydrocarbons (PAHs) to early life stages (ELS) of turbot (Psetta maxima) was studied. Embryos were exposed to dilutions of cooper, cadmium, mercury, fluoranthene, phenanthrene, pyrene and naphthalene in darkness and under visible light. Hatching success, yolk sac alterations, pericardial edema, skeletal deformities and mortality were observed. The effective concentrations (EC50, EC10,) no observed effect concentration (NOEC) and the lowest observed effect concentration (LOEC) were determined at the end of the bioassays. Exposure to metals and PAHs in ecologically relevant concentrations, either in darkness or under artificial light, caused significant lethal and sublethal effects in turbot, such as alterations in yolk sac, pericardial edema and skeletal abnormalities. According to the 96 h EC50, the ranking of acute toxicity for metals was respectively: 47.4 (46.8–59.2) μg L−1 Cu; 51.5 (20.9–91.7) μg L−1 Cd, and 83.2 (62.3–125) μg L−1 Hg. For PAHs, acute toxicities were 5.2 (4.3–6) μg L−1 pyrene, 12.3 (6.4–12.7) μg L−1 fluoranthene, 52.2 (30.4–82.7) μg L−1 phenanthrene, and 142 (55–228) μg L−1 naphthalene. Pyrene was consistently the most toxic PAH. In addition, light exposures were performed and photo-enhanced toxicity was found only for fluoranthene and pyrene. Turbot embryos were found to be more tolerant to metals and PAHs than were hatched larvae. These results suggest that, considering the short duration of the ELS turbot test and its high sensitivity, it is suitable for use as a standard test for marine fish.
Numerous studies have consistently shown an association between blunted sleep-time relative blood pressure (BP) decline (non-dipping) and increased cardiovascular disease (CVD) risk in hypertension. Normotensive persons with a non-dipper BP profile also have increased target organ damage, namely, increased left ventricular mass and relative wall thickness, reduced myocardial diastolic function, increased urinary albumin excretion, increased prevalence of diabetic retinopathy, and impaired glucose tolerance. It remains a point of contention, however, whether the non-dipper BP pattern or just elevated BP, alone, is the most important predictor of advanced target organ damage and future CVD events. Accordingly, we investigated the role of dipping status and ambulatory BP level as contributing factors for CVD morbidity and mortality in the MAPEC (Monitorización Ambulatoria para Predicción de Eventos Cardiovasculares, i.e., Ambulatory Blood Pressure Monitoring for Prediction of Cardiovascular Events) study. We prospectively studied 3344 individuals (1718 men/1626 women), 52.6 ± 14.5 (mean ± SD) yrs of age, during a median follow-up of 5.6 yrs. BP was measured by ambulatory monitoring (ABPM) for 48 h at baseline, and again annually or more frequently (quarterly) if treatment adjustment was required in treated hypertensive patients. At baseline, those with ABPM-substantiated hypertension were randomized to one of two treatment-time regimen groups: (i) ingestion of all prescribed hypertension medications upon awakening or (ii) ingestion of the entire dose of ≥1 of them at bedtime. Those found to be normotensive at baseline were untreated but followed and evaluated by repeated ABPM like the hypertensive patients. Participants were divided into four investigated categories on the basis of dipping status and ambulatory BP: (i) dipper vs. non-dipper, and (ii) normal ambulatory BP if the awake systolic (SBP)/diastolic (DBP) BP means were <135/85 mm Hg and the asleep SBP/DBP means were <120/70 mm Hg, and elevated ambulatory BP otherwise. Cox survival analyses, adjusted for significant confounding variables, documented that non-dippers had significantly higher CVD risk than dippers, whether they had normal (p = .017) or elevated ambulatory BP (p < .001). Non-dippers with normal awake and asleep SBP and DBP means, who accounted for 21% of the studied population, had similar hazard ratio (HR) of CVD events (1.61 [95% confidence interval, CI: 1.09-2.37]) as dippers with elevated ambulatory BP (HR: 1.54 [95% CI: 1.01-2.36]; p = .912 between groups). These results remained mainly unchanged for treated and untreated patients analyzed separately. Our findings document that the risk of CVD events is influenced not only by ambulatory BP elevation, but also by blunted nighttime BP decline, even within the normotensive range, thus supporting ABPM as a requirement for proper CVD risk assessment in the general population. The elevated CVD risk in "normotensive" individuals with a non-dipper BP profile represents a clear paradox, as those persons do not have "normal BP" or low CVD risk. Our findings also indicate the need to redefine the concepts of normotension/hypertension, so far established on the unique basis of BP level, mainly if not exclusively measured at the clinic, independently of circadian BP pattern.
Genetic recombination is a fundamental evolutionary mechanism promoting biological adaptation. Using engineered recombinants of the small single-stranded DNA plant virus, Maize streak virus (MSV), we experimentally demonstrate that fragments of genetic material only function optimally if they reside within genomes similar to those in which they evolved. The degree of similarity necessary for optimal functionality is correlated with the complexity of intragenomic interaction networks within which genome fragments must function. There is a striking correlation between our experimental results and the types of MSV recombinants that are detectable in nature, indicating that obligatory maintenance of intragenome interaction networks strongly constrains the evolutionary value of recombination for this virus and probably for genomes in general.
